当前位置:首页 - 行情中心 - 亚太药业(002370) - 财务分析 - 现金流量表

亚太药业

(002370)

  

流通市值:47.65亿  总市值:47.65亿
流通股本:7.46亿   总股本:7.46亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金45,882,217.33225,955,460.31146,928,758.5689,348,452.08
  收到其他与经营活动有关的现金3,913,663.1449,779,354.4236,121,132.6835,185,164.7
  经营活动现金流入小计49,795,880.47275,734,814.73183,049,891.24124,533,616.78
  购买商品、接受劳务支付的现金8,544,107.92104,480,130.7153,945,864.3926,748,846.04
  支付给职工以及为职工支付的现金22,530,444.8167,346,780.751,439,097.136,570,938.16
  支付的各项税费6,190,404.4617,206,501.9614,931,678.167,459,829.03
  支付其他与经营活动有关的现金14,729,815.0957,805,039.2539,184,293.4125,857,352.36
  经营活动现金流出小计51,994,772.28246,838,452.62159,500,933.0696,636,965.59
  经营活动产生的现金流量净额-2,198,891.8128,896,362.1123,548,958.1827,896,651.19
二、投资活动产生的现金流量:
  收回投资收到的现金20,000,00061,175,934.5531,175,934.55329,615.14
  取得投资收益收到的现金45,718.391,111,988.31912,448.6910,465.4
  处置固定资产、无形资产和其他长期资产收回的现金净额-9,199.617,9007,900
  处置子公司及其他营业单位收到的现金净额-174,780,657.82126,268,279.93126,268,279.93
  收到的其他与投资活动有关的现金64,450.672,119,972.0450,767,599.9650,675,408.16
  投资活动现金流入小计20,110,169.06239,197,752.33209,132,163.04178,191,668.63
  购建固定资产、无形资产和其他长期资产支付的现金1,983,027.335,052,612.634,351,564.632,244,962
  投资支付的现金50,000,00060,000,00060,000,000-
  投资活动现金流出小计51,983,027.3365,052,612.6364,351,564.632,244,962
  投资活动产生的现金流量净额-31,872,858.27174,145,139.7144,780,598.41175,946,706.63
三、筹资活动产生的现金流量:
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---0
  偿还债务支付的现金-277,225,300277,225,300277,225,300
  分配股利、利润或偿付利息支付的现金-37,371,378.3437,371,378.3437,371,378.34
  筹资活动现金流出平衡项目-000
  筹资活动现金流出小计-314,596,678.34314,596,678.34314,596,678.34
  筹资活动产生的现金流量净额平衡项目-000
  筹资活动产生的现金流量净额--314,596,678.34-314,596,678.34-314,596,678.34
五、现金及现金等价物净增加额-34,071,750.08-111,555,176.53-146,267,121.75-110,753,320.52
  加:期初现金及现金等价物余额608,143,546.73719,698,723.26719,698,723.26719,698,723.26
  期末现金及现金等价物余额574,071,796.65608,143,546.73573,431,601.51608,945,402.74
补充资料:
  净利润-96,307,827.65-105,176,469.82
  资产减值准备-23,103,284.03-5,029,349
  固定资产和投资性房地产折旧-25,984,748.44-14,227,000.21
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-25,984,748.44-14,227,000.21
  无形资产摊销-5,619,912.2-2,896,448.04
  长期待摊费用摊销-156,600-100,440
  处置固定资产、无形资产和其他长期资产的损失-57,942.49--
  固定资产报废损失-73,387.54-19,076.46
  公允价值变动损失--830,085.38--952,429.21
  财务费用-32,584,779.17-34,642,973.19
  投资损失--150,238,962.52--150,281,649.56
  递延所得税-124,512.81-142,864.37
    递延所得税负债增加-124,512.81-142,864.37
  存货的减少--49,442,609.96-1,330,008.62
  经营性应收项目的减少-59,313,266.19--630,494.73
  经营性应付项目的增加--13,059,258.42-17,061,757.18
  债务转为资本-17,081,344--
  现金的期末余额-608,143,546.73-608,945,402.74
  减:现金的期初余额-719,698,723.26-719,698,723.26
  现金及现金等价物的净增加额--111,555,176.53--110,753,320.52
公告日期2026-04-252026-04-252025-10-292025-08-30
审计意见(境内)标准无保留意见
TOP↑